Ligand modifications to reduce the relative resistance of multi-drug resistant HIV-1 protease

Tamaria G. Dewdney, Yong Wang, Zhigang Liu, Shiv K. Sharma, Samuel J. Reiter, Joseph S. Brunzelle, Iulia A. Kovari, Patrick M. Woster, Ladislau C. Kovari*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    1 Scopus citations


    Proper proteolytic processing of the HIV-1 Gag/Pol polyprotein is required for HIV infection and viral replication. This feature has made HIV-1 protease an attractive target for antiretroviral drug design for the treatment of HIV-1 infected patients. To examine the role of the P1 and P1′positions of the substrate in inhibitory efficacy of multi-drug resistant HIV-1 protease 769 (MDR 769), we performed a series of structure-function studies. Using the original CA/p2 cleavage site sequence, we generated heptapeptides containing one reduced peptide bond with an L to F and A to F double mutation at P1 and P1′ (F-r-F), and an A to F at P1′ (L-r-F) resulting in P1/P1′ modified ligands. Here, we present an analysis of co-crystal structures of CA/p2 F-r-F, and CA/p2 L-r-F in complex with MDR 769. To examine conformational changes in the complex structure, molecular dynamic (MD) simulations were performed with MDR769-ligand complexes. MD trajectories show the isobutyl group of both the lopinavir analog and the CA/p2 L-r-F substrate cause a conformational change of in the active site of MDR 769. IC50 measurements suggest the non identical P1/P1′ ligands (CA/p2 L-r-F and lopinavir analog) are more effective against MDR proteases as opposed to identical P1/P1′ligands. Our results suggest that a non identical P1/P1′composition may be more favorable for the inhibition of MDR 769 as they induce conformational changes in the active site of the enzyme resulting in disruption of the two-fold symmetry of the protease, thus, stabilizing the inhibitor in the active site.

    Original languageEnglish (US)
    Pages (from-to)7430-7434
    Number of pages5
    JournalBioorganic and Medicinal Chemistry
    Issue number23
    StatePublished - Dec 1 2013


    • Crystallography
    • Drug design
    • Drug resistance
    • HIV-1 protease
    • Lopinavir

    ASJC Scopus subject areas

    • Biochemistry
    • Molecular Medicine
    • Molecular Biology
    • Pharmaceutical Science
    • Drug Discovery
    • Clinical Biochemistry
    • Organic Chemistry

    Fingerprint Dive into the research topics of 'Ligand modifications to reduce the relative resistance of multi-drug resistant HIV-1 protease'. Together they form a unique fingerprint.

    Cite this